Evaluation of spatio-temporal variability in Land Surface Temperature: A case study of Zonguldak, Turkey

A. Şekertekin,S. Kutoglu,S. Kaya

DOI: https://doi.org/10.1007/s10661-015-5032-2

Abstract:

What problem does this paper attempt to address?

Micropeptides: potential treatment strategies for cancer

He Zhou,Yan Wu,Ji Cai,Dan Zhang,Dongfeng Lan,Xiaofang Dai,Songpo Liu,Tao Song,Xianyao Wang,Qinghong Kong,Zhixu He,Jun Tan,Jidong Zhang

DOI: https://doi.org/10.1186/s12935-024-03281-w

IF: 6.429

2024-04-16

Cancer Cell International

Abstract:Some noncoding RNAs (ncRNAs) carry open reading frames (ORFs) that can be translated into micropeptides, although noncoding RNAs (ncRNAs) have been previously assumed to constitute a class of RNA transcripts without coding capacity. Furthermore, recent studies have revealed that ncRNA-derived micropeptides exhibit regulatory functions in the development of many tumours. Although some of these micropeptides inhibit tumour growth, others promote it. Understanding the role of ncRNA-encoded micropeptides in cancer poses new challenges for cancer research, but also offers promising prospects for cancer therapy. In this review, we summarize the types of ncRNAs that can encode micropeptides, highlighting recent technical developments that have made it easier to research micropeptides, such as ribosome analysis, mass spectrometry, bioinformatics methods, and CRISPR/Cas9. Furthermore, based on the distribution of micropeptides in different subcellular locations, we explain the biological functions of micropeptides in different human cancers and discuss their underestimated potential as diagnostic biomarkers and anticancer therapeutic targets in clinical applications, information that may contribute to the discovery and development of new micropeptide-based tools for early diagnosis and anticancer drug development.

oncology
Clinical prospects and research strategies of long non-coding RNA encoding micropeptides.

Xinyi Wang,Zhen Zhang,Chengyu Shi,Ying Wang,Tianhua Zhou,Aifu Lin

DOI: https://doi.org/10.3724/zdxbyxb-2023-0128

2023-01-01

Abstract:Long non-coding RNAs (lncRNAs) which are usually thought to have no protein coding ability, are widely involved in cell proliferation, signal transduction and other biological activities. However, recent studies have suggested that short open reading frames (sORFs) of some lncRNAs can encode small functional peptides (micropeptides). These micropeptides appear to play important roles in calcium homeostasis, embryonic development and tumorigenesis, suggesting their potential as therapeutic targets and diagnostic biomarkers. Currently, bioinformatic tools as well as experimental methods such as ribosome mapping and in vitro translation are applied to predict the coding potential of lncRNAs. Furthermore, mass spectrometry, specific antibodies and epitope tags are used for validating the expression of micropeptides. Here, we review the physiological and pathological functions of recently identified micropeptides as well as research strategies for predicting the coding potential of lncRNAs to facilitate the further research of lncRNA encoded micropeptides.
Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors

Kang Wen,Xin Chen,Jingyao Gu,Zhenyao Chen,Zhaoxia Wang

DOI: https://doi.org/10.1186/s12929-024-01047-0

2024-06-15

Journal of Biomedical Science

Abstract:Within the intricate tapestry of molecular research, noncoding RNAs (ncRNAs) were historically overshadowed by a pervasive presumption of their inability to encode proteins or peptides. However, groundbreaking revelations have challenged this notion, unveiling select ncRNAs that surprisingly encode peptides specifically those nearing a succinct 100 amino acids. At the forefront of this epiphany stand lncRNAs and circRNAs, distinctively characterized by their embedded small open reading frames (sORFs). Increasing evidence has revealed different functions and mechanisms of peptides/proteins encoded by ncRNAs in cancer, including promotion or inhibition of cancer cell proliferation, cellular metabolism (glucose metabolism and lipid metabolism), and promotion or concerted metastasis of cancer cells. The discoveries not only accentuate the depth of ncRNA functionality but also open novel avenues for oncological research and therapeutic innovations. The main difficulties in the study of these ncRNA-derived peptides hinge crucially on precise peptide detection and sORFs identification. Here, we illuminate cutting-edge methodologies, essential instrumentation, and dedicated databases tailored for unearthing sORFs and peptides. In addition, we also conclude the potential of clinical applications in cancer therapy.

cell biology,medicine, research & experimental
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA

Pan Wu,Yongzhen Mo,Miao Peng,Ting Tang,Yu Zhong,Xiangying Deng,Fang Xiong,Can Guo,Xu Wu,Yong Li,Xiaoling Li,Guiyuan Li,Zhaoyang Zeng,Wei Xiong

DOI: https://doi.org/10.1186/s12943-020-1147-3

IF: 37.3

2020-02-04

Molecular Cancer

Abstract:Abstract Non-coding RNAs do not encode proteins and regulate various oncological processes. They are also important potential cancer diagnostic and prognostic biomarkers. Bioinformatics and translation omics have begun to elucidate the roles and modes of action of the functional peptides encoded by ncRNA. Here, recent advances in long non-coding RNA (lncRNA) and circular RNA (circRNA)-encoded small peptides are compiled and synthesized. We introduce both the computational and analytical methods used to forecast prospective ncRNAs encoding oncologically functional oligopeptides. We also present numerous specific lncRNA and circRNA-encoded proteins and their cancer-promoting or cancer-inhibiting molecular mechanisms. This information may expedite the discovery, development, and optimization of novel and efficacious cancer diagnostic, therapeutic, and prognostic protein-based tools derived from non-coding RNAs. The role of ncRNA-encoding functional peptides has promising application perspectives and potential challenges in cancer research. The aim of this review is to provide a theoretical basis and relevant references, which may promote the discovery of more functional peptides encoded by ncRNAs, and further develop novel anticancer therapeutic targets, as well as diagnostic and prognostic cancer markers.

oncology,biochemistry & molecular biology
Micropeptides derived from long non-coding RNAs: Computational analysis and functional roles in breast cancer and other diseases

Saisai Chen,Mengru Liu,Weizhen Yi,Huagang Li,Qingsheng Yu

DOI: https://doi.org/10.1016/j.gene.2024.149019

IF: 3.913

2025-01-30

Gene

Abstract:Long non-coding RNAs (lncRNAs), once thought to be mere transcriptional noise, are now revealing a hidden code. Recent advancements like ribosome sequencing have unveiled that many lncRNAs harbor small open reading frames and can potentially encode functional micropeptides. Emerging research suggests these micropeptides, not the lncRNAs themselves, play crucial roles in regulating homeostasis, inflammation, metabolism, and especially in breast cancer progression. This review delves into the rapidly evolving computational tools used to predict and validate lncRNA-encoded micropeptides. We then explore the diverse functions and mechanisms of action of these micropeptides in breast cancer pathogenesis, with a focus on their roles in various species. Ultimately, this review aims to illuminate the functional landscape of lncRNA-encoded micropeptides and their potential as therapeutic targets in cancer.
Translation of noncoding RNAs and cancer

Bo Zhou,Huan Yang,Chuan Yang,Yu-Lu Bao,Shi-Ming Yang,Jiao Liu,Yu-Feng Xiao,Yu-lu Bao,Shi-ming Yang,Yu-feng Xiao

DOI: https://doi.org/10.1016/j.canlet.2020.10.002

IF: 9.756

2021-01-01

Cancer Letters

Abstract:The human genome contains thousands of noncoding RNAs (ncRNAs), which are thought to lack open reading frames (ORFs) and cannot be translated. Some ncRNAs reportedly have important functions, including epigenetic regulation, chromatin remolding, protein modification, and RNA degradation, but the functions of most ncRNAs remain elusive. Through the application and development of ribosome profiling and sequencing technologies, an increasing number of studies have discovered the translation of ncRNAs. Although ncRNAs were initially defined as noncoding RNAs, a number of ncRNAs actually contain ORFs that are translated into peptides. Here, we summarize the available methods, tools, and databases for identifying and validating ncRNA-encoded peptides/proteins, and the recent findings regarding ncRNA-encoded small peptides/proteins in cancer are compiled and synthesized. Importantly, the role of ncRNA-encoding peptides/proteins has application prospects in cancer research, but some potential challenges remain unresolved. The aim of this review is to provide a theoretical basis that might promote the discovery of more peptides/proteins encoded by ncRNAs and aid the further development of novel diagnostic and prognostic cancer markers and therapeutic targets.

oncology
LncRNA-encoded peptides in cancer

Yaguang Zhang

DOI: https://doi.org/10.1186/s13045-024-01591-0

2024-08-12

Abstract:Long non-coding RNAs (lncRNAs), once considered transcriptional noise, have emerged as critical regulators of gene expression and key players in cancer biology. Recent breakthroughs have revealed that certain lncRNAs can encode small open reading frame (sORF)-derived peptides, which are now understood to contribute to the pathogenesis of various cancers. This review synthesizes current knowledge on the detection, functional roles, and clinical implications of lncRNA-encoded peptides in cancer. We discuss technological advancements in the detection and validation of sORFs, including ribosome profiling and mass spectrometry, which have facilitated the discovery of these peptides. The functional roles of lncRNA-encoded peptides in cancer processes such as gene transcription, translation regulation, signal transduction, and metabolic reprogramming are explored in various types of cancer. The clinical potential of these peptides is highlighted, with a focus on their utility as diagnostic biomarkers, prognostic indicators, and therapeutic targets. The challenges and future directions in translating these findings into clinical practice are also discussed, including the need for large-scale validation, development of sensitive detection methods, and optimization of peptide stability and delivery.
Current understanding of functional peptides encoded by lncRNA in cancer

Hua Tian,Lu Tang,Zihan Yang,Yanxi Xiang,Qi Min,Mengshuang Yin,Huili You,Zhangang Xiao,Jing Shen

DOI: https://doi.org/10.1186/s12935-024-03446-7

2024-07-19

Abstract:Dysregulated gene expression and imbalance of transcriptional regulation are typical features of cancer. RNA always plays a key role in these processes. Human transcripts contain many RNAs without long open reading frames (ORF, > 100 aa) and that are more than 200 bp in length. They are usually regarded as long non-coding RNA (lncRNA) which play an important role in cancer regulation, including chromatin remodeling, transcriptional regulation, translational regulation and as miRNA sponges. With the advancement of ribosome profiling and sequencing technologies, increasing research evidence revealed that some ORFs in lncRNA can also encode peptides and participate in the regulation of multiple organ tumors, which undoubtedly opens a new chapter in the field of lncRNA and oncology research. In this review, we discuss the biological function of lncRNA in tumors, the current methods to evaluate their coding potential and the role of functional small peptides encoded by lncRNA in cancers. Investigating the small peptides encoded by lncRNA and understanding the regulatory mechanisms of these functional peptides may contribute to a deeper understanding of cancer and the development of new targeted anticancer therapies.
Prenatal diagnosis of cytochrome-deficient chronic granulomatous disease

Michio Nakamura,S. Imajoh‐ohmi,S. Kanegasaki,H. Kurozumi,Kodo Sato,S. Kato,Y. Miyazaki

DOI: https://doi.org/10.1016/0140-6736(90)91635-N

IF: 202.731

1990-07-14

The Lancet

Abstract:
Micropeptides translated from putative long non-coding RNAs

Junhong Li,Lei Qu,Lingjie Sang,Xinyu Wu,Anlan Jiang,Jian Liu,Aifu Lin

DOI: https://doi.org/10.3724/abbs.2022010

IF: 3.7

2022-01-01

Acta Biochimica et Biophysica Sinica

Abstract:Long non-coding RNAs (IncRNAs) transcribed in mammals and eukaryotes were thought to have no protein coding capability. However, recent studies have suggested that plenty of IncRNAs are mis-annotated and virtually contain coding sequences which are translated into bona fide functional peptides by ribosomal machinery, and these functional peptides are called micropeptides or small peptides. Here we review the rapidly advancing field of micropeptides translated from putative IncRNAs, describe the strategies for their identification, and elucidate their critical roles in many fundamental biological processes. We also discuss the prospects of research in micropeptides and the potential applications of micropeptides.
MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

Jing-Jia Ye,Jiang Cao

DOI: https://doi.org/10.3748/wjg.v20.i15.4288

IF: 5.374

2014-01-01

World Journal of Gastroenterology

Abstract:MicroRNAs are evolutionarily conserved small non-coding RNA molecules encoded by eukaryotic genomic DNA, and function in post-transcriptional regulation of gene expression via base-pairing with complementary sequences in target mRNAs, resulting in translational repression or degradation of target mRNAs. They represent one of the major types of epigenetic modification and play important roles in all aspects of cellular activities. Altered expression of microRNAs has been found in various human diseases including cancer. Many efforts have been made to discover the characteristic microRNA expression profiles, to understand the roles of aberrantly expressed microRNAs and underlying mechanisms in different cancers. With the application of DNA microarray, real-time quantitative polymerase chain reaction and other molecular biology techniques, increasing evidence has been accumulated which reveal that aberrant microRNAs can be detected not only intracellularly within the cancer cells, but also extracellularly in plasma of patients, postulating the potential of aberrant microRNAs as promising diagnostic/prognostic markers and attracting therapeutic targets. This review is intended to provide the most recent advances in microRNA studies in one of the most common cancers, colorectal cancer, especially the identification of those specifically altered microRNAs in colorectal cancer, validation for their relevance to clinical pathological parameters of patients, functional analyses and potential applications of these microRNAs.
MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

Huiyin Lan,Haiqi Lu,Xian Wang,Hongchuan Jin

DOI: https://doi.org/10.1155/2015/125094

2015-01-01

BioMed Research International

Abstract:MicroRNAs (miRNAs) are a group of small noncoding RNAs (ncRNAs) that posttranscriptionally regulate gene expression by targeting their corresponding messenger RNAs (mRNAs). Dysregulated miRNAs have been considered as a new type of ‘‘oncomiRs” or ‘‘tumor suppressors,” playing essential roles in cancer initiation and progression. Using genome-wide detection methods, ubiquitously aberrant expression profiles of miRNAs have been identified in a broad array of human cancers, showing great potential as novel diagnostic and prognostic biomarkers of cancer with high specificity and sensitivity. The detectable miRNAs in tissue, blood, and other body fluids with high stability provide an abundant source for miRNA-based biomarkers in human cancers. Despite the fact that an increasing number of potential miRNA biomarkers have been reported, the transition of miRNAs-based biomarkers from bench to bedside still necessitates addressing several challenges. In this review, we will summarize our current understanding of miRNAs as potential biomarkers in human cancers.
Exploring the Dark Matter of Human Proteome: The Emerging Role of Non-Canonical Open Reading Frame (ncORF) in Cancer Diagnosis, Biology, and Therapy

Anni Ge,Curtis Chan,Xiaolong Yang

DOI: https://doi.org/10.3390/cancers16152660

2024-07-27

Cancers

Abstract:Cancer develops from abnormal cell growth in the body, causing significant mortalities every year. To date, potent therapeutic approaches have been developed to eradicate tumor cells, but intolerable toxicity and drug resistance can occur in treated patients, limiting the efficiency of existing treatment strategies. Therefore, searching for novel genes critical for cancer progression and therapeutic response is urgently needed for successful cancer therapy. Recent advances in bioinformatics and proteomic techniques have allowed the identification of a novel category of peptides encoded by non-canonical open reading frames (ncORFs) from historically non-coding genomic regions. Surprisingly, many ncORFs express functional microproteins that play a vital role in human cancers. In this review, we provide a comprehensive description of different ncORF types with coding capacity and technological methods in discovering ncORFs among human genomes. We also summarize the carcinogenic role of ncORFs such as pTINCR and HOXB-AS3 in regulating hallmarks of cancer, as well as the roles of ncORFs such as HOXB-AS3 and CIP2A-BP in cancer diagnosis and prognosis. We also discuss how ncORFs such as AKT-174aa and DDUP are involved in anti-cancer drug response and the underestimated potential of ncORFs as therapeutic targets.

oncology
Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough

Qiangnu Zhang,Liping Liu

DOI: https://doi.org/10.1016/j.canlet.2024.216691

IF: 9.756

2024-04-01

Cancer Letters

Abstract:Traditionally, non-coding RNAs (ncRNAs) are regarded as a class of RNA transcripts that lack encoding capability; however, advancements in technology have revealed that some ncRNAs contain small open reading frames (sORFs) that are capable of encoding micropeptides of approximately 150 amino acids in length. sORF-encoded micropeptides (SEPs) have emerged as intriguing entities in hepatocellular carcinoma (HCC) research, shedding light on this previously unexplored realm. Recent studies have highlighted the regulatory functions of SEPs in the occurrence and progression of HCC. Some SEPs exhibit inhibitory effects on HCC, but others facilitate its development. This discovery has revolutionized the landscape of HCC research and clinical management. Here, we introduce the concept and characteristics of SEPs, summarize their associations with HCC, and elucidate their carcinogenic mechanisms in HCC metabolism, signaling pathways, cell proliferation, and metastasis. In addition, we propose a step-by-step workflow for the investigation of HCC-associated SEPs. Lastly, we discuss the challenges and prospects of applying SEPs in the diagnosis and treatment of HCC. This review aims to facilitate the discovery, optimization, and clinical application of HCC-related SEPs, inspiring the development of early diagnostic, individualized, and precision therapeutic strategies for HCC.

oncology
Biochemical targets of the micropeptides encoded by lncRNAs

Bi-Ying Wang,Qi Gao,Yan Sun,Xiao-Bo Qiu

DOI: https://doi.org/10.1016/j.ncrna.2024.04.005

2024-04-27

Non-coding RNA Research

Abstract:Long noncoding RNAs (lncRNAs) are a group of transcripts longer than 200 nucleotides, which play important roles in regulating various cellular activities by the action of the RNA itself. However, about 40 % of lncRNAs in human cells are potentially translated into micropeptides (also referred to as microproteins) usually shorter than 100 amino acids. Thus, these lncRNAs may function by both RNAs directly and their encoded micropeptides. The micropeptides encoded by lncRNAs may regulate transcription, translation, protein phosphorylation or degradation, or subcellular membrane functions. This review attempts to summarize the biochemical targets of the micropeptides-encoded by lncRNAs, which function by both RNAs and micropeptides, and discuss their associations with various diseases and their potentials as drug targets.

biochemistry & molecular biology
The role of polypeptides encoded by ncRNAs in cancer

Jiayuan Huang,Ping Yang,Wei Pan,Fan Wu,Jianhua Qiu,Zhongliang Ma

DOI: https://doi.org/10.1016/j.gene.2024.148817

IF: 3.913

2024-01-01

Gene

Abstract:It was previously thought that ncRNA could not encode polypeptides, but recent reports have challenged this notion. As research into ncRNA progresses, it is increasingly clear that it serves roles beyond traditional mechanisms, playing significant regulatory roles in various diseases, notably cancer, which is responsible for 70% of human deaths. Numerous studies have highlighted the diverse regulatory mechanisms of ncRNA that are pivotal in cancer initiation and progression. The role of ncRNA-encoded polypeptides in cancer regulation has gained prominence. This article explores the newly identified regulatory functions of these polypeptides in three types of ncRNA—lncRNA, pri-miRNA, and circRNA. These polypeptides can interact with proteins, influence signaling pathways, enhance miRNA stability, and regulate cancer progression, malignancy, resistance, and other clinical challenges. Furthermore, we discuss the evolutionary significance of these polypeptides in the transition from RNA to protein, examining their emergence and conservation throughout evolution.
Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets

Didier Meseure,Kinan Drak Alsibai,Andre Nicolas,Ivan Bieche,Antonin Morillon

DOI: https://doi.org/10.1155/2015/320214

2015-01-01

BioMed Research International

Abstract:Recent advances in genome-wide analysis have revealed that 66% of the genome is actively transcribed into noncoding RNAs (ncRNAs) while less than 2% of the sequences encode proteins. Among ncRNAs, high-resolution microarray and massively parallel sequencing technologies have identified long ncRNAs (>200 nucleotides) that lack coding protein function. LncRNAs abundance, nuclear location, and diversity allow them to create in association with protein interactome, a complex regulatory network orchestrating cellular phenotypic plasticity via modulation of all levels of protein-coding gene expression. Whereas lncRNAs biological functions and mechanisms of action are still not fully understood, accumulating data suggest that lncRNAs deregulation is pivotal in cancer initiation and progression and metastatic spread through various mechanisms, including epigenetic effectors, alternative splicing, and microRNA-like molecules. Mounting data suggest that several lncRNAs expression profiles in malignant tumors are associated with prognosis and they can be detected in biological fluids. In this review, we will briefly discuss characteristics and functions of lncRNAs, their role in carcinogenesis, and their potential usefulness as diagnosis and prognosis biomarkers and novel therapeutic targets.

biotechnology & applied microbiology,medicine, research & experimental
Potential therapies for non-coding RNAs in breast cancer

Ruonan Li,Yuxin Ji,Ruyin Ye,Guohui Tang

DOI: https://doi.org/10.3389/fonc.2024.1452666

IF: 4.7

2024-09-21

Frontiers in Oncology

Abstract:Breast cancer (BC) is one of the frequent tumors that seriously endanger the physical and mental well-being in women with strong heterogeneity, and its pathogenesis involves multiple risk factors. Depending on the type of BC, hormonal therapy, targeted therapy, and immunotherapy are the current systemic treatment options along with conventional chemotherapy. Despite significant progress in understanding BC pathogenesis and therapeutic options, there is still a need to identify new therapeutic targets and develop more effective treatments. According to recent sequencing and profiling studies, non-coding (nc) RNAs genes are deregulated in human cancers via deletion, amplification, abnormal epigenetic, or transcriptional regulation, and similarly, the expression of many ncRNAs is altered in breast cancer cell lines and tissues. The ability of single ncRNAs to regulate the expression of multiple downstream gene targets and related pathways provides a theoretical basis for studying them for cancer therapeutic drug development and targeted delivery. Therefore, it is far-reaching to explore the role of ncRNAs in tumor development and their potential as therapeutic targets. Here, our review outlines the potential of two major ncRNAs, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) as diagnostic and prognostic biomarkers as well as targets for new therapeutic strategies in breast cancer.

oncology
Multi-Omic Approaches in Cancer-Related Micropeptide Identification

Katarina Vrbnjak,Raj Nayan Sewduth

DOI: https://doi.org/10.3390/proteomes12030026

2024-09-13

Proteomes

Abstract:Despite the advances in modern cancer therapy, malignant diseases are still a leading cause of morbidity and mortality worldwide. Conventional treatment methods frequently lead to side effects and drug resistance in patients, highlighting the need for novel therapeutic approaches. Recent findings have identified the existence of non-canonical micropeptides, an additional layer of the proteome complexity, also called the microproteome. These small peptides are a promising class of therapeutic agents with the potential to address the limitations of current cancer treatments. The microproteome is encoded by regions of the genome historically annotated as non-coding, and its existence has been revealed thanks to recent advances in proteomic and bioinformatic technology, which dramatically improved the understanding of proteome complexity. Micropeptides have been shown to be biologically active in several cancer types, indicating their therapeutic role. Furthermore, they are characterized by low toxicity and high target specificity, demonstrating their potential for the development of better tolerated drugs. In this review, we survey the current landscape of known micropeptides with a role in cancer progression or treatment, discuss their potential as anticancer agents, and describe the methodological challenges facing the proteome field of research.
Non-coding RNAs as therapeutic targets in cancer and its clinical application

Xuejiao Leng,Mengyuan Zhang,Yujing Xu,Jingjing Wang,Ning Ding,Yancheng Yu,Shanliang Sun,Weichen Dai,Xin Xue,Nianguang Li,Ye Yang,Zhihao Shi

DOI: https://doi.org/10.1016/j.jpha.2024.02.001

IF: 14.026

2024-02-10

Journal of Pharmaceutical Analysis

Abstract:Highlights • The classification, synthesis, and function of non-coding RNA are introduced. • The oncogenes and tumor suppressor genes of three types of non-coding RNA (circRNA, lncRNA, and miRNA) have been summarized. • The review covers the clinical application of non-coding RNA as a therapeutic target for cancer treatment. Cancer genomics has led to the discovery of numerous oncogenes and tumor suppressor genes that play critical roles in cancer development and progression. Oncogenes promote cell growth and proliferation, whereas tumor suppressor genes inhibit cell growth and division. The dysregulation of these genes can lead to the development of cancer. Recent studies have focused on non-coding RNAs (ncRNAs), including circular RNA (circRNA), long non-coding RNA (lncRNA), and microRNA (miRNA), as therapeutic targets for cancer. In this article, we discuss the oncogenes and tumor suppressor genes of ncRNAs associated with different types of cancer and their potential as therapeutic targets. Here, we highlight the mechanisms of action of these genes and their clinical applications in cancer treatment. Understanding the molecular mechanisms underlying cancer development and identifying specific therapeutic targets are essential steps towards the development of effective cancer treatments. Graphical abstract Download : Download high-res image (215KB) Download : Download full-size image

pharmacology & pharmacy

Evaluation of spatio-temporal variability in Land Surface Temperature: A case study of Zonguldak, Turkey

Micropeptides: potential treatment strategies for cancer

Clinical prospects and research strategies of long non-coding RNA encoding micropeptides.

Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors

Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA

Micropeptides derived from long non-coding RNAs: Computational analysis and functional roles in breast cancer and other diseases

Translation of noncoding RNAs and cancer

LncRNA-encoded peptides in cancer

Current understanding of functional peptides encoded by lncRNA in cancer

Prenatal diagnosis of cytochrome-deficient chronic granulomatous disease

Micropeptides translated from putative long non-coding RNAs

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

Exploring the Dark Matter of Human Proteome: The Emerging Role of Non-Canonical Open Reading Frame (ncORF) in Cancer Diagnosis, Biology, and Therapy

Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough

Biochemical targets of the micropeptides encoded by lncRNAs

The role of polypeptides encoded by ncRNAs in cancer

Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets

Potential therapies for non-coding RNAs in breast cancer

Multi-Omic Approaches in Cancer-Related Micropeptide Identification

Non-coding RNAs as therapeutic targets in cancer and its clinical application